1. Home
  2. INAB vs BLIN Comparison

INAB vs BLIN Comparison

Compare INAB & BLIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IN8bio Inc.

INAB

IN8bio Inc.

SELL

Current Price

$1.21

Market Cap

11.8M

Sector

Health Care

ML Signal

SELL

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

HOLD

Current Price

$0.77

Market Cap

12.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
INAB
BLIN
Founded
2016
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.1M
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
INAB
BLIN
Price
$1.21
$0.77
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $7.00
N/A
AVG Volume (30 Days)
44.0K
★ 50.5K
Earning Date
11-05-2026
08-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $13,568,000.00
Revenue This Year
N/A
$20.26
Revenue Next Year
N/A
$21.08
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.88
$0.69
52 Week High
$2.73
$1.45

Technical Indicators

Market Signals
Indicator
INAB
BLIN
Relative Strength Index (RSI) 47.46 31.67
Support Level $0.92 $0.70
Resistance Level $1.50 $1.05
Average True Range (ATR) 0.09 0.07
MACD -0.01 -0.00
Stochastic Oscillator 33.33 13.27

Price Performance

Historical Comparison
INAB
BLIN

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: